Libya vs Myanmar: Cause of death, by non-communicable diseases, ages 15-59, female
Libya
60.9%
in 2021
Myanmar
61.5%
in 2021
Libya rank
95th
Myanmar rank
93rd
Cause of death, by non-communicable diseases, ages 15-59, female over time
- Libya
- Myanmar
How they compare
Myanmar currently reports 61.5% against 60.9% in Libya, a difference of 0.6%.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Libya ahead.
Libya ranks 95th and Myanmar ranks 93rd of 185 countries.
Across the 3 decades both report, Libya averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Libya | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 68.5% | 54.2% | 14.3% | Libya |
| 2010s | 68.3% | 65.2% | 3.1% | Libya |
| 2020s | 62.9% | 65.7% | 2.9% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, Libya or Myanmar?
- Myanmar, at 61.5% against 60.9% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between Libya and Myanmar?
- 0.6%, with Myanmar ahead.
- How many years of comparable data are there for Libya and Myanmar?
- 6 years are reported by both, from 2000 to 2021.
- How do Libya and Myanmar rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- Libya ranks 95th and Myanmar ranks 93rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.